C12Y 204/0104
Glycoprotein-fucosylgalactoside alpha-n-acetylgalactosaminyltransferase
Official title: Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase (2.4.1.40)
C12Y204/0104 (Glycoprotein-fucosylgalactoside alpha-n-acetylgalactosaminyltransferase) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 2
- Inventors
- 13
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Cancer immunotherapies to promote hyperacute rejection13 Nov 2025US 2025/0345420 A1
- Microorganism for producing human milk oligosaccharide29 Feb 2024US 2024/0067937 A1OligoScience Biotechnology GmbH
- Modification of blood type antigens31 Aug 2023US 2023/0272429 A1Sana Biotechnology, Inc.
- Microorganism for producing human milk oligosaccharide5 Nov 2020US 2020/0347366 A1OligoScience Biotechnology GmbH
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.